1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy.

Slides:



Advertisements
Similar presentations
Medical Retina and Macular Diseases
Advertisements

1 Diabetic macula edema. ?  Microaneurysms  CWS  Hard exudates  Beading of vessels  IRMA  NVD/NVE  DME- Types 2.
How Far Would You Go To Address Diabetic Microvascular Complications?
Evan (Jake) Waxman MD PhD
DIABETIC RETINOPATHY Diabetic retinopathy is a frequent cause of blindness. The exact cause of diabetic microvascular disease is unknown.
Welcome to CNIB’s InFocus Webinar Series
21/4/ Pegaptanib Sodium ( MACUGEN) for Macular Edema Secondary to Central Retinal Vein Occlusion Mahmood J Showail.
Canadian Diabetes Association Clinical Practice Guidelines Retinopathy Chapter 30 Shelley R. Boyd, Andrew Advani, Filiberto Altomare, Frank Stockl.
SHAWN RICHARDS, MD MOSES LAKE CLINIC MOSES LAKE, WA Common Retinal Diseases.
Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012
“Prevention of Blindness” Is diabetic retinopathy a preventable disease? By Amr ElKamshoushy, MD.
Prevalence of Diabetic Retinopathy In Diabetic patients cared for at the Family Care Center at RCRMC Kam Chan, DO [ role of BP & glycemic control ]
DIABETIC RETINOPATHY.
Fundoscopic Examination
M.R.AKHLAGHI MD  It is based on ophthalmoscopic signs.
Diabetic Retinopathy Keri Burton Marissa Ramirez Okono Stacey Garner Stephany Harris.
By: Marc Wentz, Regina Carson, Jonathan Nissen, Cydney Williams
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
DIABETES AND THE EYE. EPIDEMIOLOGY Commonest cause of blindness in the population of working age in developed countries Prevalence of DR of any severity.
Nonsurgical management of diabetic retinopathy Ghanbari MD 1388:11:30.
Ines Serrano MD Evan Waxman MD PhD
1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Edward J. Bastyr III, MD Promoting Clear Identification of Diabetic Peripheral.
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
به نام خداوند جان و خرد. دکتر نادر طاهری متخصص داخلی فوق تخصص غدد Refrence:ADA(2012) and William textbook of endocrinology.
Diabetic Retinopathy Steven Sanislo, M.D. Assistant Professor Stanford University Department of Ophthalmology.
Diabetic Retinopathy Tina Duke Salazar Sandy Haney Sharon Grissom.
Diabetic Retinopathy. Diabetic retinopathy is the most common cause of new cases of blindness among adults years of age. Each year, between 12,000.
Topic assignment : medical ophthalmology
Diabetic Retinopathy Norma Maddox Donna Charlotte.
Global Diabetes Prevalence Is Projected to Increase 242% Between 2000 and 2030 Global data 2000: 151 million patients 2010: 221 million patients 2030:
Diabetes and Your Eyes.
Personalised Eye Consultation (PEC) to improve outcomes in DR Dr Eva Fenwick (Research Fellow) Behavioural Research in Ophthalmology Prue Spencer, Project.
Diabetes and the Eyes Kenyon Anderson, O.D.. Blindness Risk Diabetic eye disease, caused by diabetes, is a leading cause of blindness and vision loss.
Diabetic Retinopathy (DR) Ayesha S Abdullah
Diabetic Retinopathy.
Hypertensive Retinopathy
Diabetic Retinopathy. Early detection, education, and research are the keys to preventing diabetic retinopathy. Skilled professionals, such as TVI, are.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 6.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
Diagnosis & Management of Diabetic Eye Disease A. Paul Chous, M.A., O.D., F.A.A.O. Tacoma, WA Specializing in Diabetes Eye Care & Education Part 5.
OPHTHALMOLOGY DIABETES
Diabetic Retinopathy (DR) Ayesha S Abdullah
The Diabetic Retinopathy Clinical Research Network
Josephine Carlos-Raboca, M.D. Makati Medical Center
Diabetic Retinopathy Alan D. Letson, MD Professor & William H. Havener Chair in Ophthalmology Department of Ophthalmology Part I:
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Philip Anderton BOptom PhD Visiting Optometrist Manilla Health Service HNEAHS.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
Prevalence of Diabetes in Adults (20-79 years), million adults with diabetes worldwide, or 1 in 11 adults.
BRVO. Present by Sattar Heidari MD General ophthalmologist.
Old Fibrotic Vascular tissue in End-Stage Proliferative Retinopathy
How Diabetes Steals Vision from Your Patients
The Diabetic Retinopathy Clinical Research Network
Prevalence of Diabetic Retinopathy
Glossophobia.
Dr.Ravi kant Associate Professor Medicine ,AIIMS Rishikesh
Classification and treatment of Diabetic Retinopathy
Diabetic Retinopathy Screening: A Public Health Perspective
Systemic Diseases.
Department of Ophthalmology AIIMS, Rishikesh
Ocular Manifestations of Diabetes
DIABETIC RETINOPATHY Süleyman ÖZEN.
당뇨황반부종에서의 레이저 치료 의정부 성모병원 안과 양지욱.
3. Background diabetic retinopathy
DIABETES AND THE EYE.
The Diabetic Retinopathy Clinical Research Network
January 16, 2019.
FLAME Lecture: 13 Marshburn
A: Probability of retinopathy-free survival.
Presentation transcript:

1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy

2 Overview Clinical Manifestations and Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema Disease Epidemiology Inadequacy of Current Diagnostic Codes Proposed Modifications and Clarification Discussion

3 Diabetic Retinopathy (DR) Diabetic Retinopathy is a disorder of the retinal vasculature that eventually develops to some degree in nearly all diabetic patients 1 —Third most common cause of blindness in the US and leading cause of blindness in individuals years of age 2 —Significant impairment of quality of life 1 Significant resources are spent to treat patients with DR —Estimated $422M in total direct health care expenditures 3 Treatment includes: —Control of diabetes-associated metabolic abnormalities (e.g. hyperglycemia; hyperlipidemia; hypertension) —Laser photocoagulation and vitrectomy 1. American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy., National Society to Prevent Blindness: Vision Problems in the US. New York, Prevent Blindness America, American Diabetes Association. Economic Cost of Diabetes in US in Diabetes Care 26: , 2003

4 AAO Disease Severity Scale Dilated Opthalmoscopy Findings No Apparent Retinopathy No Abnormalities Mild Non-Proliferative Diabetic Retinopathy Microaneurysms only Moderate Non-Proliferative Diabetic Retinopathy More than just microaneurysms, but less than severe NPDR Severe Non-Proliferative Diabetic Retinopathy Any of the following: - More than 20 intraretinal hemorrhages in each of four quadrants - Definite beading in two or more quadrants - Prominent intraretinal mircovascular anomalies in one or more quadrants And no signs of proliferative retinopathy Proliferative Diabetic Retinopathy One or both of the following: - Neovascularization - Vitreous/preretinal hemorrhage Natural History – Diabetic Retinopathy American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy., 2003

5 Diabetic Macular Edema (DME) Defined as retinal thickening or hard exudates in posterior pole resulting from increased vascular permiability 1 Frequent manifestation of diabetic retinopathy. Diabetic Macular Edema can occur in both the non-proliferative and proliferative stages of diabetic retinopathy Clinically significant macular edema (CSDME) may result in DR patients losing vision 2 —DME within 500 μm of the center of the retina, or within 1500 μm and one disc area or larger in size —Generally the threshold at which laser photocoagulation is applied 1. American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy., Ciulla TA et al: Diabetic Retinopathy and Macular Edema. Diabetes Care. 26:

6 Epidemiology Sight-Threatening DR is defined as proliferative DR or severe nonproliferative DR or macular edema 4.1 MM 0.8 MM Source: Kempen et al, Arch Ophthalmol 2004; 122:

7 Inadequacy of Existing Codes Background Diabetic Retinopathy (362.01) —Older term that does not represent current AAO/NEI language —Does not allow for clear understanding of disease progression —Includes Macular Edema: not allowing for a clear understanding of the Non-Proliferative Diabetic Retinopathy patients at risk for vision loss

8 Maintain Background diabetic retinopathy —Remove Diabetic macular edema & diabetic retinal edema from Maintain Proliferative diabetic retinopathy Create four unique codes to describe the different stages of Diabetic Retinopathy Mild non-proliferative diabetic retinopathy Moderate non-proliferative diabetic retinopathy Severe non-proliferative diabetic retinopathy Diabetic macular edema (code first for retinopathy) Diabetic retinal edema Modification to Diabetic Retinopathy Codes

9 Conclusion DR and DME are frequent, progressive complications of diabetes associated with significant morbidity and costs Current ICD-9-CM codes do not allow for categorization of the different stages of DR resulting in the loss of valuable information on the epidemiology and costs of the disease Modification of current codes will better represent the clinical presentation of DR and DME  Background diabetic retinopathy  Proliferative diabetic retinopathy  Mild non-proliferative diabetic retinopathy  Moderate non-proliferative diabetic retinopathy  Severe non-proliferative diabetic retinopathy  Diabetic macular edema (code first for retinopathy) Diabetic retinal edema